Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability
Go back to Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.19 | 52 Week High | $45.34 | |||
| Open | $3.19 | 52 Week Low | $15.92 | |||
| Day High | $3.19 | P/E | 1.37 | |||
| Day Low | $3.19 | EPS | $2.33 | |||
| Volume | 40 | |||||
